Ruihua Pharmaceutical key facts
- Operator of a pharmaceutical manufacturing company intended to research, develop, produce, and sell pharmaceutical intermediates, fine chemicals, and biotechnology products.
- Notable investors include Fuyang Yingke Fund Management.
- Status: Privately Held (backing).
Who backs Ruihua Pharmaceutical
1- ·Watch Ruihua Pharmaceutical: the Monday email on marks, rounds and moves
Ruihua Pharmaceutical funding rounds
No funding rounds for Ruihua Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ruihua Pharmaceutical investors
1 investor is on record for Ruihua Pharmaceutical, including Fuyang Yingke Fund Management.
About Ruihua Pharmaceutical
Operator of a pharmaceutical manufacturing company intended to research, develop, produce, and sell pharmaceutical intermediates, fine chemicals, and biotechnology products. The company offers a diverse product portfolio, including recombinant proteins, enzymes, bioactive peptides, amino acids, alcohols, ketones, and esters, enabling pharmaceutical, food, cosmetics, and daily chemical industries to enhance product quality and meet specific application needs.
- Sector
- Healthcare
- HQ
- Fuyang, China
- Founded
- 2018
- Employees
- 2
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Ruihua Pharmaceutical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.